SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors rally centers on the pending FDA decision on deramiocel for Duchenne muscular dystrophy, with traders reacting to managements confidence, the applications final-review status, and analyst upgrades. Many are bullish and speculate about short covering, while others stress that approval is uncertain and a rejection could bring significant downside.

RUM Group, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

RUM is drawing attention after strong quarterly results highlighted record revenue and its first positive adjusted EBITDA, driven largely by Quake AI and its GPU-cloud business. Bulls see evidence that the AI infrastructure pivot is gaining traction and tout high short interest, while skeptics point to financing needs, potential data-center delays and continuing losses.

Figure Technology Solutions, Inc. is a blockchain-native capital marketplace, which engages in connecting origination, funding, and secondary market activity. It operates through the following segments: FTI, Markets, and Other. The FTI segment offers Figure Connect which generates ecosystem and technology fees, and originates, sells, and securitizes home equity line of credit (HELOC) loans that it services. The Markets segment utilizes blockchain technology to develop an exchange for digital assets and credit, with new product offerings including providing interest-bearing stable coin deposits. The company was founded by Michael Scott Cagney and June Ou in 2018 and is headquartered in Reno, NV.

Figure Technology Solutions Inc. - Ordinary Shares - Class A

Figure Technology Solutions Inc

FIGR is drawing attention amid sharp price swings and debate over whether its growth in HELOC lending and blockchain-based financial infrastructure justifies its valuation. Bears point to insider selling and persistent weakness, while bulls emphasize expanding loan volume and the longer-term tokenization opportunity; traders also speculate about short-covering and crypto-linked moves.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLakes FDA review of its sonelokimab application for hidradenitis suppurativa is the dominant catalyst, with traders focused on the filings acceptance and review timeline. Bulls point to the drugs clinical results and potential strategic value, while skeptics emphasize regulatory and competitive risks and worry that launching independently could require more capital.

Amprius Technologies, Inc. engages in the development, manufacture, and market of lithium-ion batteries for mobility applications, including the aviation, electric vehicle and light electric vehicle industries. It operates through the following geographical segments: North America, EMEA, and Asia Pacific. The company was founded by Mark C. Platshon in 2008 and headquartered in Fremont, CA.

Amprius Technologies Inc

Amprius quarterly results showed strong revenue growth, improving margins and a raised outlook, but an earnings miss and negative adjusted EBITDA coincided with a sharp share-price decline. Traders are split between concerns about near-term profitability and claims of short- or options-driven selling, while many long-term holders view the pullback as an opportunity.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

AUPH is drawing attention over ongoing generic-patent litigation involving Lupkynis, as repeated court extensions keep investors focused on the timing of possible settlements. Some traders speculate a resolution could be approaching, while others are frustrated by the delays and the companys limited communication.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeaves stronger-than-expected Q3 results, raised outlook and large backlog have fueled a sharp rally and renewed interest in the AI infrastructure trade; the CEOs canceled stock-sale plan and comments on customer prepayments also eased some financing concerns. Traders are debating whether short covering can extend the rebound, while skeptics point to heavy debt, interest costs and potential dilution.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

Golds sharp swings are being driven by shifting Fed-rate expectations: hotter inflation and stronger yields and the dollar pressured GLD, while a subsequent rebound has drawn dip buyers. Traders are split between viewing the move as a temporary bounce near support and expecting further downside as rate-hike bets persist.

The Clorox Co. engages in the manufacture and marketing of consumer and professional products. It operates through the following business segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment consists of cleaning products, professional products and vitamins, minerals and supplements mainly marketed and sold in the United States. The Household segments consists of bags and wraps, grilling products and cat litter marketed and sold in the United States. The Lifestyle segment refers to food, natural personal care products and water-filtration products marketed and sold in the United States. The International segment covers products sold outside the United States, excluding natural personal care products. The company was founded by Edward Hughes, Charles Husband, William Hussey, Rufus Myers, and Archibald Taft on May 3, 1913 and is headquartered in Oakland, CA.

Clorox Co.

Unconfirmed takeover and M&A chatterincluding claims of European investor interestis drawing attention to Clorox, with some traders citing elevated volume and a sharp recent run while others are taking profits or cautioning that the rumor is unverified.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

RVMD is drawing attention after its first quarterly report as RASONQUE launched, with traders highlighting a strong initial commercial showing but noting the stock sold off despite the upbeat results. The debate centers on whether launch momentum can continue amid high spending and concerns that sales could slow.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
